Incorporate Lotus Stem In Your Diet Today To Achieve These Health Benefits
Lotus stem, also known as kamal kakdi in Hindi, is the long, cylindrical stalk of the lotus plant that grows underwater and is commonly used in Asian and Indian cuisines. It has a crisp texture and a mildly sweet, earthy flavour. Rich in dietary fibre, vitamins like C and B6, potassium, iron, and antioxidants, lotus stem is highly nutritious. When consumed as part of a balanced diet, it can contribute to better digestion, blood circulation, immunity, and even skin health. Its low calorie and high fibre content make it especially beneficial for weight management and overall wellness. In this article, we discuss the many benefits of lotus stem.
10 Ways lotus stem can boost health
1. Improves digestion
Lotus stem is high in dietary fibre, which adds bulk to the stool and promotes regular bowel movements. This helps prevent constipation and supports a healthy gut. Fibre also encourages the growth of good gut bacteria, enhancing nutrient absorption and digestive efficiency.
2. Supports heart health
Rich in potassium, lotus stem helps regulate blood pressure by balancing sodium levels and relaxing blood vessels. This can reduce the strain on the heart and lower the risk of hypertension and other cardiovascular diseases.
3. Boosts immunity
The vitamin C content in lotus stem strengthens the immune system by enhancing the production of white blood cells and acting as a powerful antioxidant. It protects the body against infections, colds, and oxidative stress caused by free radicals.
4. Aids in weight management
Being low in calories and fat yet high in fibre, lotus stem keeps you full for longer periods, curbing unnecessary hunger pangs. This helps reduce overall calorie intake and supports healthy weight loss or maintenance.
5. Enhances skin health
Lotus stem contains vitamin C and polyphenols, which help combat oxidative damage to the skin. These nutrients support collagen production, improve skin elasticity, and reduce the appearance of wrinkles, giving the skin a healthy glow.
6. Improves blood circulation
Iron and copper present in lotus stem support the production of red blood cells, improving oxygen delivery throughout the body. This helps prevent fatigue, boosts energy levels, and promotes healthy skin tone.
7. Manages blood sugar levels
The fibre in lotus stem slows the absorption of sugar into the bloodstream, preventing spikes in blood glucose levels. This makes it a useful addition to the diets of those managing diabetes or insulin resistance.
8. Reduces inflammation
Lotus stem contains anti-inflammatory compounds like flavonoids and alkaloids, which may help reduce chronic inflammation in the body. This can be particularly beneficial for people dealing with arthritis, metabolic syndrome, or inflammatory gut issues.
9. Supports liver function
Some compounds in lotus stem, especially antioxidants and polyphenols, help detoxify the liver by neutralising toxins and reducing oxidative damage. A healthier liver means better metabolism and improved overall health.
10. Improves mental function
B vitamins such as vitamin B6 found in lotus stem are known to aid in the production of neurotransmitters like serotonin and dopamine. This can help regulate mood, reduce anxiety, and support better cognitive functioning over time.
Lotus stem is not just a delicious addition to curries, stir-fries, and pickles, it's a functional food that can contribute to holistic health when consumed regularly as part of a balanced diet.
Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
Delhi HC sets aside appointment of NCISMC chairperson
The Delhi High Court on Friday (June 6, 2025) quashed the appointment of Vaidya Jayant Yeshwant Deopujari as Chairperson of the National Commission for Indian System of Medicine, holding that he does not meet the qualification prescribed for appointment to the office. The court passed the order on two petitions filed by Ved Prakash Tyagi, former president of the erstwhile Central Council for Indian Medicine, and Dr. Raghunandan Sharma challenging the appointment of Mr. Deopujari as the chairperson of the commission (NCISMC). The Ministry of Personnel, Public Grievances, and Pensions had issued a circular on June 9, 2021, appointing Mr. Deopujari as the commission's chairperson. The petitioners have alleged that Mr. Deopujari could not be appointed as the chairperson of the commission as he does not hold a postgraduate degree, mandated under the National Commission for Indian System of Medicine Act, 2020 (NCISM Act). The court held that Mr. Deopujari possessed a PhD degree, whereas the requisite degree was an MD or any other equivalent master's degree in any discipline of the Indian System of Medicine. The PhD degree that was awarded to him by Pune University did not presuppose acquisition of a lower qualification (Master's Degree in Ayurveda), it said. Ineligible person 'We have no hesitation to hold that the expression 'Post-Graduate Degree' occurring in Section 4(2) of the NCISM Act, 2020, in the context it has been used, would mean a Master's Degree (MD) in any discipline of Indian System of Medicine, which the respondent does not possess, and, therefore, he lacks the requisite qualification for being appointed to the office in question,' the court said. Mr. Tyagi's plea said the commission was a governing body for all matters relating to education and regulation of Indian medicine in the country. 'Thus, the interests of a large number of people/students/Indian medicine practitioners shall be adversely and severely affected if an ineligible person is allowed to continue as the chairperson of such a critical statutory body,' he added. The court noted that the counsel representing the Commission has stated in the court that the process of selection and appointment of the Chairperson of the Commission has commenced. 'Accordingly, we direct that the said process shall be completed with expedition, and while conducting the process of selection, the observations made hereinabove in this judgment shall be taken into account,' the court added.
Business Standard
2 hours ago
- Business Standard
G.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and Nutraceuticals
India PR Distribution Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India's pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality. What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL's impressive timeline of achievements includes: - 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities - 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals - 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market -2018: Entry into the sports nutrition space - 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics - 2023: Establishment of a dedicated vaccine division to expand immunization solutions Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R & D, and a global network of manufacturing and distribution partners. "At GCCPL, innovation is not a buzzword--it's the foundation of our growth strategy," said Founder and Chairman Gautam Shah. "We're proud to be one of India's few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer." Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probiotic--both showcasing GCCPL's commitment to introducing clinically backed, innovative health solutions to India. With a sterling reputation for regulatory compliance, deep market research, and financial integrity--as affirmed by CRISIL's highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products. About G.C Chemie Pharmie Pvt. Ltd. Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today's market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Indian pharma market grows 7.2% in May led by chronic therapies
Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches Sanket Koul New Delhi The Indian Pharma Market (IPM) grew 7.2 per cent in May this year with almost all major therapies showing positive growth, according to market research firm Pharmarack. Data suggest that big chronic therapies such as cardiac and anti-infectives, which account for nearly 25 per cent of the overall domestic market, recorded value growth of 11.7 per cent and 7.6 per cent, respectively. On the other hand, several smaller supergroups such as urology and antineoplastics, which made up 2 per cent each of the IPM's sales value for the month, also recorded double-digit growth in May at 12.3 per cent and 11.7 per cent, said Sheetal Sapale, vice-president, commercial, Pharmarack. Data suggest that the overall value growth for the IPM in May was driven by price growth and new introductions. The IPM also reported a minuscule 0.4 per cent unit growth during the month, with the chronic segments such as antidiabetics (6.1 per cent) and cardiac (4.8 per cent) performing better than the overall market figure. Experts believe that the antidiabetic segment saw a 6.1 per cent rise in volume in May due to a key drug, empagliflozin, going off-patent, as companies launched several plain and combination medications in the segment. Growth in the moving annual turnover (MAT) for the IPM between June 2024 and May 2025 stood at 8.1 per cent, leading to a total turnover of over Rs 2.29 trillion, while volumes in the domestic market grew by 1.1 per cent. The MAT of leading therapy areas such as cardiac, gastrointestinal and anti-infectives, which constitute around 38 per cent of the pharmaceutical market, showed robust volume growth at 10.4 per cent, 9.5 per cent and 6.5 per cent, respectively. While the top 20 brands in the IPM registered modest monthly value growth in the domestic market during the month, Sun Pharma and Dr Reddy's posted significant monthly value growth at 11.2 per cent each. They were followed by Torrent Pharma and Ipca Laboratories at 10.8 per cent, and Alkem Laboratories at 10.3 per cent monthly value growth. According to Pharmarack data, GlaxoSmithKline's (GSK) antibiotic medication Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands at the MAT level, with sales worth Rs 819 crore and Rs 810 crore, respectively.
